ProShares UltraShort Nasdaq Biotechnology Plans Quarterly Dividend of $0.06 (BIS)

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) announced a quarterly dividend on Wednesday, March 20th, Wall Street Journal reports. Investors of record on Thursday, March 21st will be given a dividend of 0.0636 per share on Wednesday, March 27th. This represents a $0.25 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Wednesday, March 20th.

ProShares UltraShort Nasdaq Biotechnology stock traded up $0.18 during midday trading on Wednesday, hitting $16.37. 51,261 shares of the stock were exchanged, compared to its average volume of 111,136. ProShares UltraShort Nasdaq Biotechnology has a 1 year low of $15.38 and a 1 year high of $27.62.

ILLEGAL ACTIVITY NOTICE: “ProShares UltraShort Nasdaq Biotechnology Plans Quarterly Dividend of $0.06 (BIS)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2019/03/20/proshares-ultrashort-nasdaq-biotechnology-plans-quarterly-dividend-of-0-06-bis.html.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.

Read More: What are the Different Types of Leveraged Buyouts?

Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.